Skip to main content
. 2020 Jan 28;26(4):424–432. doi: 10.3748/wjg.v26.i4.424

Table 1.

Characteristics of 77 patients with gastric cancer

Characteristics Number of patients, n (%)
Mean age, yr (range) 71.1 (30-86)
Gender
Male 49 (63.6)
Female 28 (36.4)
Depth of invasion
T1 28 (36.4)
T2 25 (32.5)
T3 21 (27.3)
T4 3 (3.9)
Lymph node metastasis
N0 34 (44.2)
N1 14 (18.2)
N2 13 (16.9)
N3 16 (20.8)
Histological type
Well-differentiated adenocarcinoma 42 (54.5)
Poorly-differentiated adenocarcinoma 29 (46.9)
Signet-ring cell carcinoma 1 (1.3)
Carcinoma with lymphoid stroma 3 (3.9)
Mucinous adenocarcinoma 1 (1.3)
Endocrine carcinoma 1 (1.3)
Stage of disease
I 29 (37.7)
II 23 (29.9)
III 12 (15.6)
IV 13 (16.9)
H. pylori infection (IgG titer)
Negative (< 20 U/mL) 17 (22.1)
Positive (≥ 20 U/mL) 60 (77.9)
PGI
≤ 70 ng/mL 76 (98.7)
> 70 ng/mL 1 (1.3)
PG I/PG II
≤ 3 64 (83.1)
> 3 13 (16.9)
PG method
Positive (PG I ≤ 70 and PG I/II ≤ 3) 63 (81.8)
Negative (except the cases described above) 14 (18.2)
ABCD stratification (H. pylori infection/PG method)
A (negative/negative) 3 (3.9)
B (positive/negative) 11 (14.3)
C (positive/positive) 49 (63.6)
D (negative/positive) 14 (18.2)
KK-LC-1
Positive 63 (81.8)
Negative 14 (18.2)

Positive of H. pylori infection; IgG titer ≥ 20 U/mL, Positive of PG method; PG I ≤ 70 ng/mL and PG I/PG II ≤ 3. KK-LC-1: Kita–Kyushu lung cancer antigen-1; H. pylori: Helicobacter pylori.